A citation-based method for searching scientific literature

Xiwei Sun, Angli Xue, Ting Qi, Dan Chen, Dandan Shi, Yang Wu, Zhili Zheng, Jian Zeng, Jian Yang. Cancer Res 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.
David R Gandara, Sarah M Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Geoff Otto, Christine Malboeuf,[...]. Nat Med 2018
507
33

Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations.
Jian Carrot-Zhang, Giovanny Soca-Chafre, Nick Patterson, Aaron R Thorner, Anwesha Nag, Jacqueline Watson, Giulio Genovese, July Rodriguez, Maya K Gelbard, Luis Corrales-Rodriguez,[...]. Cancer Discov 2021
10
33

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
Matthew D Hellmann, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong Seok Lee, Gregory A Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak Burgers, Pamela Salman,[...]. N Engl J Med 2018
33

A Compendium of Mutational Signatures of Environmental Agents.
Jill E Kucab, Xueqing Zou, Sandro Morganella, Madeleine Joel, A Scott Nanda, Eszter Nagy, Celine Gomez, Andrea Degasperi, Rebecca Harris, Stephen P Jackson,[...]. Cell 2019
178
33

A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Alaa Moamer, Ibrahim Y Hachim, Najat Binothman, Ni Wang, Jean-Jacques Lebrun, Suhad Ali. EBioMedicine 2019
6
33

Genomic landscape of lung adenocarcinoma in East Asians.
Jianbin Chen, Hechuan Yang, Audrey Su Min Teo, Lidyana Bte Amer, Faranak Ghazi Sherbaf, Chu Quan Tan, Jacob Josiah Santiago Alvarez, Bingxin Lu, Jia Qi Lim, Angela Takano,[...]. Nat Genet 2020
73
33

Signatures of negative selection in the genetic architecture of human complex traits.
Jian Zeng, Ronald de Vlaming, Yang Wu, Matthew R Robinson, Luke R Lloyd-Jones, Loic Yengo, Chloe X Yap, Angli Xue, Julia Sidorenko, Allan F McRae,[...]. Nat Genet 2018
105
33

Mutational signatures associated with tobacco smoking in human cancer.
Ludmil B Alexandrov, Young Seok Ju, Kerstin Haase, Peter Van Loo, Iñigo Martincorena, Serena Nik-Zainal, Yasushi Totoki, Akihiro Fujimoto, Hidewaki Nakagawa, Tatsuhiro Shibata,[...]. Science 2016
462
33

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Robert M Samstein, Chung-Han Lee, Alexander N Shoushtari, Matthew D Hellmann, Ronglai Shen, Yelena Y Janjigian, David A Barron, Ahmet Zehir, Emmet J Jordan, Antonio Omuro,[...]. Nat Genet 2019
33

Tobacco smoking and somatic mutations in human bronchial epithelium.
Kenichi Yoshida, Kate H C Gowers, Henry Lee-Six, Deepak P Chandrasekharan, Tim Coorens, Elizabeth F Maughan, Kathryn Beal, Andrew Menzies, Fraser R Millar, Elizabeth Anderson,[...]. Nature 2020
109
33

Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study.
Fei Ma, Quchang Ouyang, Wei Li, Zefei Jiang, Zhongsheng Tong, Yunjiang Liu, Huiping Li, Shiying Yu, Jifeng Feng, Shusen Wang,[...]. J Clin Oncol 2019
86
33

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.
D J Slamon, G M Clark, S G Wong, W J Levin, A Ullrich, W L McGuire. Science 1987
33

Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study.
Sibo Sun, Yiqian Liu, Ann-Kathrin Eisfeld, Fuxi Zhen, Shidai Jin, Wen Gao, Tongfu Yu, Liang Chen, Wei Wang, Wei Chen,[...]. Front Oncol 2019
10
33

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).
B C Pestalozzi, D Zahrieh, K N Price, S B Holmberg, J Lindtner, J Collins, D Crivellari, M F Fey, E Murray, O Pagani,[...]. Ann Oncol 2006
274
33

Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Véronique Diéras, David Miles, Sunil Verma, Mark Pegram, Manfred Welslau, José Baselga, Ian E Krop, Kim Blackwell, Silke Hoersch, Jin Xu,[...]. Lancet Oncol 2017
224
33

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer.
Yan Wang, Chuanhua Zhao, Lianpeng Chang, Ru Jia, Rongrui Liu, Yun Zhang, Xuan Gao, Jin Li, Rongrong Chen, Xuefeng Xia,[...]. EBioMedicine 2019
29
33

Implementing TMB measurement in clinical practice: considerations on assay requirements.
Reinhard Büttner, John W Longshore, Fernando López-Ríos, Sabine Merkelbach-Bruse, Nicola Normanno, Etienne Rouleau, Frédérique Penault-Llorca. ESMO Open 2019
112
33


Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial.
Ahmad Awada, Ramon Colomer, Kenichi Inoue, Igor Bondarenko, Rajendra A Badwe, Georgia Demetriou, Soo-Chin Lee, Ajay O Mehta, Sung-Bae Kim, Thomas Bachelot,[...]. JAMA Oncol 2016
137
33

Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer.
Weijun Wang, Haiping He, Nagore I Marín-Ramos, Shan Zeng, Steven D Swenson, Hee-Yeon Cho, Jie Fu, Paul M Beringer, Josh Neman, Ligang Chen,[...]. Neuro Oncol 2021
3
33

Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
Adam M Brufsky, Musa Mayer, Hope S Rugo, Peter A Kaufman, Elizabeth Tan-Chiu, Debu Tripathy, Iulia Cristina Tudor, Lisa I Wang, Melissa G Brammer, Mona Shing,[...]. Clin Cancer Res 2011
217
33

Pyrotinib enhances the radiosensitivity of HER2‑overexpressing gastric and breast cancer cells.
Tingting Huang, Xiaoxiao Luo, Bili Wu, Ping Peng, Yuhong Dai, Guangyuan Hu, Hong Qiu, Xianglin Yuan. Oncol Rep 2020
5
33

Brain Metastasis in Breast Cancer Patients-Need for Improvement.
Isabell Witzel, Leticia Oliveira-Ferrer, Volkmar Müller. Cancers (Basel) 2020
1
100

Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors.
Neil T Conlon, Jeffrey J Kooijman, Suzanne J C van Gerwen, Winfried R Mulder, Guido J R Zaman, Irmina Diala, Lisa D Eli, Alshad S Lalani, John Crown, Denis M Collins. Br J Cancer 2021
3
33

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Nancy U Lin, Virginia Borges, Carey Anders, Rashmi K Murthy, Elisavet Paplomata, Erika Hamilton, Sara Hurvitz, Sherene Loi, Alicia Okines, Vandana Abramson,[...]. J Clin Oncol 2020
101
33


HER2-positive breast cancer brain metastasis: A new and exciting landscape.
Alexandra S Zimmer, Amanda E D Van Swearingen, Carey K Anders. Cancer Rep (Hoboken) 2020
12
33

[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice].
G H Song, H P Li, L J DI, Y Yan, H F Jiang, L Xu, D G Wan, Y Li, M P Wang, Y Xiao,[...]. Beijing Da Xue Xue Bao Yi Xue Ban 2020
3
33

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases.
Rachel A Freedman, Rebecca S Gelman, Carey K Anders, Michelle E Melisko, Heather A Parsons, Anne M Cropp, Kelly Silvestri, Christine M Cotter, Kathryn P Componeschi, Juan M Marte,[...]. J Clin Oncol 2019
134
33

Pyrotinib: First Global Approval.
Hannah A Blair. Drugs 2018
45
33

CNS metastases in breast cancer: old challenge, new frontiers.
Nancy U Lin, Laleh Amiri-Kordestani, Diane Palmieri, David J Liewehr, Patricia S Steeg. Clin Cancer Res 2013
117
33

Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis.
Ying Lin, Mingxi Lin, Jian Zhang, Biyun Wang, Zhonghua Tao, Yiqun Du, Sheng Zhang, Jun Cao, Leiping Wang, Xichun Hu. Cancer Res Treat 2020
8
33

The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
Costas D Arvanitis, Gino B Ferraro, Rakesh K Jain. Nat Rev Cancer 2020
249
33

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Mothaffar F Rimawi, Carmine De Angelis, Alejandro Contreras, Fresia Pareja, Felipe C Geyer, Kathleen A Burke, Sabrina Herrera, Tao Wang, Ingrid A Mayer, Andres Forero,[...]. Breast Cancer Res Treat 2018
46
33

Discovery and development of pyrotinib: A novel irreversible EGFR/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer.
Xin Li, Changyong Yang, Hong Wan, Ge Zhang, Jun Feng, Lei Zhang, Xiaoyan Chen, Dafang Zhong, Liguang Lou, Weikang Tao,[...]. Eur J Pharm Sci 2017
66
33

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
Antonio C Wolff, M Elizabeth Hale Hammond, Kimberly H Allison, Brittany E Harvey, Pamela B Mangu, John M S Bartlett, Michael Bilous, Ian O Ellis, Patrick Fitzgibbons, Wedad Hanna,[...]. Arch Pathol Lab Med 2018
221
33

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. Arch Pathol Lab Med 2014
645
33

CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.
Xavier Pivot, Alexey Manikhas, Bogdan Żurawski, Ewa Chmielowska, Boguslawa Karaszewska, Rozenn Allerton, Stephen Chan, Alessandra Fabi, Paolo Bidoli, Stefania Gori,[...]. J Clin Oncol 2015
134
33


The changes in the permeability of the blood-brain barrier when under neurosurgical intervention.
A P Khokhlov, I G Fetisova, V P Chekhonin, V K Malakhovsky. Mol Chem Neuropathol 1993
2
50

Site of metastasis and breast cancer mortality: a Danish nationwide registry-based cohort study.
Anne Gulbech Ording, Uffe Heide-Jørgensen, Christian Fynbo Christiansen, Mette Nørgaard, John Acquavella, Henrik Toft Sørensen. Clin Exp Metastasis 2017
26
33

Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial.
Binghe Xu, Min Yan, Fei Ma, Xichun Hu, Jifeng Feng, Quchang Ouyang, Zhongsheng Tong, Huiping Li, Qingyuan Zhang, Tao Sun,[...]. Lancet Oncol 2021
23
33

Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641).
Xinghao Ai, Jiuwei Cui, Jiexia Zhang, Rongrong Chen, Wen Lin, Congying Xie, Anwen Liu, Junping Zhang, Weihua Yang, Xiaohua Hu,[...]. Clin Cancer Res 2021
5
33

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial.
F Montemurro, S Delaloge, C H Barrios, R Wuerstlein, A Anton, E Brain, T Hatschek, C M Kelly, C Peña-Murillo, M Yilmaz,[...]. Ann Oncol 2020
41
33

Brain metastasization of breast cancer.
Tânia Custódio-Santos, Mafalda Videira, Maria Alexandra Brito. Biochim Biophys Acta Rev Cancer 2017
38
33

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
33

Predictive Role of TP53, PIK3CA and MLL2 in ER+ HER2+ Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859].
Ji Hyun Park, Jin-Hee Ahn, Jeong Eun Kim, Kyung Hae Jung, Gyungyub Gong, Hee Jin Lee, Byung-Ho Son, Sei-Hyun Ahn, Hak-Hee Kim, Hee Jung Shin,[...]. Anticancer Res 2020
1
100

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients: A Phase I Clinical Trial.
Qiao Li, Xiuwen Guan, Shanshan Chen, Zongbi Yi, Bo Lan, Puyuan Xing, Ying Fan, Jiayu Wang, Yang Luo, Peng Yuan,[...]. Clin Cancer Res 2019
25
33

Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Qitong Chen, Dengjie Ouyang, Munawar Anwar, Ning Xie, Shouman Wang, Peizhi Fan, Liyuan Qian, Gannong Chen, Enxiang Zhou, Lei Guo,[...]. Front Oncol 2020
13
33

Permeability of Brain Tumor Vessels Induced by Uniform or Spatially Microfractionated Synchrotron Radiation Therapies.
Audrey Bouchet, Marine Potez, Nicolas Coquery, Claire Rome, Benjamin Lemasson, Elke Bräuer-Krisch, Chantal Rémy, Jean Laissue, Emmanuel L Barbier, Valentin Djonov,[...]. Int J Radiat Oncol Biol Phys 2017
25
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.